ConocoPhillips Impairment Charges increased by 40.0% to $14.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 69.6%, from $46.00M to $14.00M. Over 4 years (FY 2021 to FY 2025), Impairment Charges shows a downward trend with a -55.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High impairment charges suggest poor capital allocation or a decline in the competitive value of the company's assets.
Impairment charges are non-cash write-downs taken when the carrying value of an asset exceeds its fair market value. Thi...
Common in industries with high intangible asset bases, such as pharma and consumer goods.
cf_impairment_charges| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | -$89.00M | $764.00M | $2.00M | $2.00M | $2.00M | -$18.00M | $1.00M | $0.00 | $11.00M | $2.00M | $0.00 | $34.00M | $0.00 | $46.00M | $1.00M | $1.00M | $10.00M | $14.00M |
| QoQ Change | — | <-999% | +958.4% | -99.7% | +0.0% | +0.0% | <-999% | +105.6% | -100.0% | — | -81.8% | -100.0% | — | -100.0% | — | -97.8% | +0.0% | +900.0% | +40.0% |
| YoY Change | — | — | — | — | +0.0% | +102.2% | -102.4% | -50.0% | -100.0% | +450.0% | +111.1% | -100.0% | — | -100.0% | >999% | — | -97.1% | — | -69.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.